BetterLife Pharma Inc. (BETRF)
BETRF is quoted over the counter, not listed on an exchange. BetterLife Pharma Inc. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.
Closes: Yahoo Finance daily closes, last bar 2026-11-16.
Profile
| Field | Value |
|---|---|
| Ticker | BETRF, quoted over the counter |
| SEC CIK | 0001464165 |
| OTC Markets tier | OTCQB (price source, 2026-11-13) |
| SEC industry code | Pharmaceutical Preparations |
| Business address | Vancouver, BC |
| Incorporated in | BC |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | States substantial doubt about continuing as a going concern. "These events or conditions indicate that a material uncertainty exists that casts substantial doubts on our ability to continue as a going concern." | 20-F 2026-06-01 |
| Cash and burn | $9K cash; operating cash flow -$110K a quarter. | Report 2026-01-31 |
| Shares outstanding | 151,896,675 (2026-06-01); 145,494,883 a year earlier. | Cover page 2026-06-01 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | MNP LLP, Vancouver, Canada | PCAOB Form AP 2026-06-04 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $0 on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2026 2026-01-31 | Not filed | -$1.1M | -$439K | $9K | No debt tags | Needs four quarters | 20-F 2026-06-01 |
| Q3 2019 2018-10-31 | Not filed | -$3.4M | -$706K | $407K | $2.7M | Needs four quarters | 10-Q 2018-12-18 |
| Q2 2019 2018-07-31 | Not filed | -$1.4M | -$983K | $474K | $3.5M | Needs four quarters | 10-Q 2018-09-14 |
| Q1 2019 2018-04-30 | Not filed | -$1.6M | -$1.9M | $1.5M | $3.5M | Needs four quarters | 10-Q 2018-06-19 |
| Q4 2018 2018-01-31 | Not filed | -$327K | -$196K | $65K | $401K | Needs four quarters | 10-K 2018-05-01 |
| Q3 2018 2017-10-31 | Not filed | $531K | Not filed | $250K | $402K | Needs four quarters | 10-Q 2018-12-18 |
| Q3 2018 2017-10-30 | Not filed | $531K | -$96K | $250K | $402K | Needs four quarters | 10-Q 2018-12-18 |
| Q2 2018 2017-07-31 | Not filed | -$6K | -$39K | $10K | $394K | Needs four quarters | 10-Q 2018-09-14 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-1/A | 2010-03-16 |
| Latest annual report | 20-F | 2026-06-01 |
| Latest quarterly / interim | 6-K | 2026-09-30 |
| Latest current report | 8-K | 2019-05-21 |
| Latest proxy | DEF 14A | 2019-02-19 |
Source: SEC EDGAR submissions feed, 244 recent filings. All filings on EDGAR.
The full dossier has every filing, quarterly and annual financials, the health record and a price chart.
Open the full dossier